6 research outputs found
Bile acid profiling and quantification in biofluids using ultra-performance liquid chromatography tandem mass spectrometry
Bile acids are important end products of cholesterol metabolism. While they have been identified as key factors in lipid emulsification and absorption due to their detergent properties, bile acids have also been shown to act as signaling molecules and intermediates between the host and the gut microbiota. To further the investigation of bile acid functions in humans, an advanced platform for high throughput analysis is essential. Herein, we describe the development and application of a 15 min UPLC procedure for the separation of bile acid species from human biofluid samples requiring minimal sample preparation. High resolution time-of-flight mass spectrometry was applied for profiling applications, elucidating rich bile acid profiles in both normal and disease state plasma. In parallel, a second mode of detection was developed utilizing tandem mass spectrometry for sensitive and quantitative targeted analysis of 145 bile acid (BA) species including primary, secondary, and tertiary bile acids. The latter system was validated by testing the linearity (lower limit of quantification, LLOQ, 0.25–10 nM and upper limit of quantification, ULOQ, 2.5–5 μM), precision (≈6.5%), and accuracy (81.2–118.9%) on inter- and intraday analysis achieving good recovery of bile acids (serum/plasma 88% and urine 93%). The ultra performance liquid chromatography–mass spectrometry (UPLC-MS)/MS targeted method was successfully applied to plasma, serum, and urine samples in order to compare the bile acid pool compositional difference between preprandial and postprandial states, demonstrating the utility of such analysis on human biofluids
Objective Set of Criteria for Optimization of Sample Preparation Procedures for Ultra-High Throughput Untargeted Blood Plasma Lipid Profiling by Ultra Performance Liquid Chromatography–Mass Spectrometry
Exploratory or untargeted ultra performance
liquid chromatography–mass
spectrometry (UPLC–MS) profiling offers an overview of the
complex lipid species diversity present in blood plasma. Here, we
evaluate and compare eight sample preparation protocols for optimized
blood plasma lipid extraction and measurement by UPLC–MS lipid
profiling, including four protein precipitation methods (i.e., methanol,
acetonitrile, isopropanol, and isopropanol–acetonitrile) and
four liquid–liquid extractions (i.e., methanol combined with
chloroform, dichloromethane, and methyl-<i>tert</i> butyl
ether and isopropanol with hexane). The eight methods were then benchmarked
using a set of qualitative and quantitative criteria selected to warrant
compliance with high-throughput analytical workflows: protein removal
efficiency, selectivity, repeatability, and recovery efficiency of
the sample preparation. We found that protein removal was more efficient
by precipitation (99%) than extraction (95%). Additionally, isopropanol
appeared to be the most straightforward and robust solvent (61.1%
of features with coefficient of variation (CV) < 20%) while enabling
a broad coverage and recovery of plasma lipid species. These results
demonstrate that isopropanol precipitation is an excellent sample
preparation procedure for high-throughput untargeted lipid profiling
using UPLC–MS. Isopropanol precipitation is not limited to
untargeted profiling and could also be of interest for targeted UPLC–MS/MS
lipid analysis. Collectively, these data show that lipid profiling
greatly benefits from an isopropanol precipitation in terms of simplicity,
protein removal efficiency, repeatability, lipid recovery, and coverage
Ultrahigh-performance liquid chromatography tandem mass spectrometry with electrospray ionization quantification of tryptophan metabolites and markers of gut health in serum and plasma-application to clinical and epidemiology cohorts
A targeted ultrahigh-performance liquid chromatography tandem mass spectrometry with electrospray ionization (UHPLC-ESI-MS/MS) method has been developed for the quantification of tryptophan and its downstream metabolites from the kynurenine and serotonin pathways. The assay coverage also includes markers of gut health and inflammation, including citrulline and neopterin. The method was designed in 96-well plate format for application in multiday, multiplate clinical and epidemiology population studies. A chromatographic cycle time of 7 min enables the analysis of two 96-well plates in 24 h. To protect chromatographic column lifespan, samples underwent a two-step extraction, using solvent protein precipitation followed by delipidation via solid-phase extraction (SPE). Analytical validation reported accuracy of each analyte <20% for the lowest limit of quantification and <15% for all other quality control (QC) levels. The analytical precision for each analyte was 2.1-12.9%. To test the applicability of the method to multiplate and multiday preparations, a serum pool underwent periodic repeat analysis during a run consisting of 18 plates. The % CV (coefficient of variation) values obtained for each analyte were <15%. Additional biological testing applied the assay to samples collected from healthy control participants and two groups diagnosed with inflammatory bowel disease (IBD) (one group treated with the anti-inflammatory 5-aminosalicylic acid (5-ASA) and one group untreated), with results showing significant differences in the concentrations of picolinic acid, kynurenine, and xanthurenic acid. The short analysis time and 96-well plate format of the assay makes it suitable for high-throughput targeted UHPLC-ESI-MS/MS metabolomic analysis in large-scale clinical and epidemiological population studies.</p